In CAD patients, serum CTRP9 levels are negatively correlated with TNF-α and IL-6 levels, while positively correlated with high-density lipoprotein (HDL-C) levels (Wang et al. 2015). Here, C1QTNF9 is linked to coronary artery disorder.